Sage Therapeutics


SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders.

Industries

Employees

501-1,000

Links


Org chart

Collapse
Anne Marie Cook
SVP & General Counsel
Marjorie Stewart-Hart (she/her)
Vice President, Patient Engagement And Advocacy
Matthew Henson
Vice President, Corporate Communications
Robert A.
Senior Vice President, Strategic Insights/analytics, Field Effectiveness, Forecasting
Mollie Baird
Vice President, Head Of Clinical Development Operations
Jillian Savarese
Senior Director, Commercial Engagement & Operational Excellence
Sajedul Iqbal Cpa, Msa
Corporate Controller
Victor Gonzalez
Executive Director - Access And Reimbursement Account Management
Christine Day
Vice President | Digital Transformation, Core Technology, G&a Enablement
Michael McFarlane
Executive Director, People & Experience
Sunil Chawla
Executive Director, Supply Chain
Ashley Douglas
Manager, People & Experience
Joseph Roach
Director, Commercial Business Applications
Sujatha H.
Associate Medical Director
Greg Silvesti
Vice President | Digital Health & Innovation
Paul S. Watson
Vice President Head Of Pharmaceutical Development
Jamie Wilson
Vice President Of Quality
Upinder Bhambra
Executive Director, Head Of Drug Safety & Pharmacovigilance
Mike Lewis
Senior Director
Alexandria Costanzo (Dougherty)
Regional Business Director
Etchell Cordero
Executive Director, Business Operations
Kerry Ann O’Connell
Regional Business Director
Kurt Turner
Executive Director, US Market Access Strategy
Steven Collier
Vice President Technical Operations
Theresa Vera
Executive Medical Director

Board & advisors